salmeterol xinafoate has been researched along with Bronchitis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 12 (75.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgartner, RA; Donohue, JF; Goodwin, E; Grogan, DR; Hanania, NA; Hanrahan, JP; Sciarappa, KA | 1 |
| Blanchette, CM; Dalal, AA; Delea, TE; Hagiwara, M; Stanford, RH | 1 |
| Izquierdo Alonso, JL | 1 |
| Lipworth, BJ | 1 |
| Cox, FM; Emmett, AH; Juniper, EF; Nielsen, KE; O'Byrne, PM; Wisniewski, ME | 1 |
| Fukkuda, T | 1 |
| Jansen, HM; Koopmans, JG; Lutter, R; van der Zee, JS | 1 |
| Bourbeau, J; Christodoulopoulos, P; Hamid, Q; Maltais, F; Olivenstein, R; Yamauchi, Y | 1 |
| Johnson, M | 1 |
| Hargreave, FE; Hussack, P; Mcivor, RA; Pizzichini, E; Sears, MR; Turner, MO | 1 |
| Altieri, E; Bousquet, J; Chanez, P; Chiappara, G; Gagliardo, R; Godard, P; Térouanne, B; Vachier, I; Vic, P; Vignola, AM | 1 |
| de Jongste, JC; Verberne, AA | 1 |
| Beckett, P; Dahl, R; Howarth, PH | 1 |
| Bjermer, L; Faurschou, P; Sandström, T; Walters, EH | 1 |
| McDonald, DM | 1 |
6 review(s) available for salmeterol xinafoate and Bronchitis
| Article | Year |
|---|---|
[Clinical profile of roflumilast].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Bronchitis; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Forced Expiratory Volume; Humans; Mice; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Rats; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome; Weight Loss | 2010 |
Antagonism of long-acting beta2-adrenoceptor agonism.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchitis; Bronchodilator Agents; Drug Combinations; Drug Interactions; Ethanolamines; Formoterol Fumarate; Humans; Meta-Analysis as Topic; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate | 2002 |
[Recent study on pathogenesis of bronchial asthma and the therapeutic strategy].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchi; Bronchial Diseases; Bronchial Hyperreactivity; Bronchitis; Constriction, Pathologic; Drug Therapy, Combination; Eosinophilia; Glucocorticoids; Humans; Salmeterol Xinafoate; Theophylline | 2004 |
Beta 2-agonists as anti-inflammatory therapies in the lung.
Topics: Acute Disease; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchitis; Capillary Permeability; Ethanolamines; Formoterol Fumarate; Humans; Inflammation; Lung; Salmeterol Xinafoate | 1993 |
The effect of long-acting beta2-agonists on airway inflammation in asthmatic patients.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Bronchitis; Bronchoalveolar Lavage Fluid; Chronic Disease; Eosinophils; Humans; Lymphocytes; Mast Cells; Neutrophils; Salmeterol Xinafoate | 2000 |
The anti-inflammatory profile of inhaled corticosteroids combined with salmeterol in asthmatic patients.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Biopsy; Bronchi; Bronchitis; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Humans; Salmeterol Xinafoate | 2000 |
4 trial(s) available for salmeterol xinafoate and Bronchitis
| Article | Year |
|---|---|
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
Topics: Albuterol; Arrhythmias, Cardiac; Bronchitis; Bronchodilator Agents; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Ipratropium; Male; Middle Aged; Myocardial Ischemia; Nebulizers and Vaporizers; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Salmeterol Xinafoate; Tremor | 2008 |
Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
Topics: Administration, Inhalation; Adult; Albuterol; Analysis of Variance; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchitis; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Female; Fluticasone; Humans; Male; Middle Aged; Salmeterol Xinafoate; Treatment Outcome | 2006 |
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.
Topics: Administration, Inhalation; Aged; Albuterol; Androstadienes; Bronchitis; Bronchodilator Agents; CD8-Positive T-Lymphocytes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Immunohistochemistry; Lymphopenia; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome; Vital Capacity | 2007 |
Potential masking effects of salmeterol on airway inflammation in asthma.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Beclomethasone; Blood Proteins; Bronchial Provocation Tests; Bronchitis; Bronchoconstrictor Agents; Bronchodilator Agents; Budesonide; Cross-Over Studies; Disease Progression; Eosinophil Granule Proteins; Eosinophils; Female; Glucocorticoids; Humans; Inflammation Mediators; Leukocyte Count; Male; Methacholine Chloride; Middle Aged; Peak Expiratory Flow Rate; Placebos; Ribonucleases; Salmeterol Xinafoate; Spirometry; Sputum | 1998 |
6 other study(ies) available for salmeterol xinafoate and Bronchitis
| Article | Year |
|---|---|
Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Androstadienes; Bronchitis; Bronchodilator Agents; Chronic Disease; Cohort Studies; Drug Therapy, Combination; Female; Fluticasone; Health Care Costs; Health Services; Humans; Ipratropium; Male; Middle Aged; Salmeterol Xinafoate; Treatment Outcome | 2009 |
Relationship between quality of life and clinical status in asthma: a factor analysis.
Topics: Activities of Daily Living; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Airway Resistance; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchitis; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lung Volume Measurements; Male; Middle Aged; Nebulizers and Vaporizers; Psychometrics; Quality of Life; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Sick Role; Sickness Impact Profile; Treatment Outcome | 2004 |
Glucocorticoid receptors in bronchial epithelial cells in asthma.
Topics: Administration, Oral; Adult; Aged; Albuterol; Anti-Inflammatory Agents; Asthma; Biopsy; Bronchi; Bronchitis; Bronchodilator Agents; Budesonide; Chronic Disease; Epithelial Cells; Gene Expression Regulation; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; HSP90 Heat-Shock Proteins; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Prednisone; Proteins; Receptors, Glucocorticoid; RNA, Messenger; Salmeterol Xinafoate; Theophylline | 1998 |
Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet)
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchitis; Bronchodilator Agents; Child; Eosinophilia; Ethanolamines; Formoterol Fumarate; Humans; Lung; Salmeterol Xinafoate | 2000 |
[Chronic bronchitis. Gold standard from the internet].
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Bronchitis; Bronchodilator Agents; Cholinergic Antagonists; Critical Pathways; Drug Therapy, Combination; Fluticasone; Humans; Lung Diseases, Obstructive; Salmeterol Xinafoate | 2001 |
Angiogenesis and remodeling of airway vasculature in chronic inflammation.
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Angiopoietin-1; Animals; Asthma; Bronchitis; Bronchodilator Agents; Capillary Permeability; Chronic Disease; Disease Models, Animal; Endothelial Growth Factors; Endothelium; Humans; Inflammation; Lung; Lymphokines; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Microcirculation; Nebulizers and Vaporizers; Neovascularization, Pathologic; Pneumonia, Mycoplasma; Propanolamines; Rats; Rats, Wistar; Research; Respiratory Mucosa; Salmeterol Xinafoate; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |